Vice President, Therapeutic Lead - Immunology and Inflammatory Team
About this role
Work Schedule
Standard (Mon-Fri)
Environmental Conditions
Office
Job Description
Join Us as a Vice President, Therapeutic Lead, Project Management - Make an Impact at the Forefront of Innovation.
The Vice President, Therapeutic Lead, Immunology and Inflammatory, within our Internal Medicine Therapeutic Business Unit (TBU) is a credible business leader and subject matter expert in the immunology, inflammatory and/or dermatology therapeutic areas, responsible for leading and growing a book of business. This leader will collaborate globally across functional groups to develop, expand, and deliver on our strategic and scientific vision for the therapeutic areas. The team is committed to its mission-to establish PPD/CRG as the industry leader in all aspects of internal medicine, and to secure, retain, and grow business within this dynamic and evolving market.
Responsibilities
- Strategic and Commercial Leadership: Develop and execute a comprehensive business growth strategy for the Immunology, Inflammatory and/or Dermatology book of business, driving business expansion through pipeline analysis, market assessment, and enterprise collaboration. Identify opportunities to align internal capabilities with evolving sponsor needs and scientific advancements.
- Portfolio Oversight: Oversee planning, execution, and delivery of therapeutic studies, portfolios, and client engagements. Ensure operational excellence, scientific quality, and on-time delivery across the Immunology and Inflammatory portfolio.
- Market Intelligence & Thought Leadership: Maintain expertise in the evolving scientific, clinical, and regulatory landscape for immunology, inflammatory and/or dermatology therapeutic areas. Contribute to publications, presentations, and scientific forums to advance CRG's visibility and leadership.
- Cross-Therapeutic Integration: Collaborate with other leaders to leverage synergies across related therapeutic areas, driving operational efficiency and innovation in stud